KIORA PHARMACEUTICALS, INC. (KPRX) Total liabilities 2016–2025
KIORA PHARMACEUTICALS, INC. (KPRX) total liabilities at each fiscal year-end, per SEC filings.
$8.1MFY2025 · since FY2016: $10.1M → $8.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.1M | -24.2% |
| FY2024 | $10.7M | +41.1% |
| FY2023 | $7.6M | — |
| FY2021 | $5.6M | -0.4% |
| FY2020 | $5.6M | +59.7% |
| FY2019 | $3.5M | -34.7% |
| FY2018 | $5.3M | -67.1% |
| FY2017 | $16.2M | +61.4% |
| FY2016 | $10.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More KPRX financial trends
KPRX RevenueKPRX Net incomeKPRX Net marginKPRX Gross profitKPRX Gross marginKPRX Operating incomeKPRX Operating marginKPRX Operating cash flowKPRX Free cash flowKPRX Capital expendituresKPRX Return on equityKPRX Stock buybacksKPRX Dividends paidKPRX Total assetsKPRX Shareholders’ equityKPRX overview →